H025-0300C Screening compound: 2,9-dimethyl-6-{2-[4-(trifluoromethyl)phenyl]ethyl}-1H,2H,3H,4H,5H,6H-azepino[4,3-b]indole

H025-0300C Screening compound: 2,9-dimethyl-6-{2-[4-(trifluoromethyl)phenyl]ethyl}-1H,2H,3H,4H,5H,6H-azepino[4,3-b]indole
H025-0300C Screening compound: 2,9-dimethyl-6-{2-[4-(trifluoromethyl)phenyl]ethyl}-1H,2H,3H,4H,5H,6H-azepino[4,3-b]indole alternative view

Chemical Structure Depiction of ChemDiv screening compound H025-0300C
2,9-dimethyl-6-{2-[4-(trifluoromethyl)phenyl]ethyl}-1H,2H,3H,4H,5H,6H-azepino[4,3-b]indole

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

H025-0300C

Molecular Formula

C23H25F3N2 (C23 H25 F3 N2)

Compound Name

2,9-dimethyl-6-{2-[4-(trifluoromethyl)phenyl]ethyl}-1H,2H,3H,4H,5H,6H-azepino[4,3-b]indole

IUPAC name

29-dimethyl-6-{2-[4-(trifluoromethyl)phenyl]ethyl}-1H2H3H4H5H6H-azepino[43-b]indole

SMILES

Cc(cc1)cc2c1n(CCc1ccc(C(F)(F)F)cc1)c1c2CN(C)CCC1

InChI

InChI=1S/C23H25F3N2/c1-16-5-10-22-19(14-16)20-15-27(2)12-3-4-21(20)28(22)13-11-17-6-8-18(9-7-17)23(24,25)26/h5-10,14H,3-4,11-13,15H2,1-2H3

InChI Key

QOKSLUVRRGQTTL-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27214557

Chemical and Physical Properties

Saltdata

HCl

Molecular Weight

386.46

Hydrogen Bond Acceptors Count

1.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

4.00

Number of Nitrogen and Oxygen Atoms

2

Partition Coefficient, logP

5.642

Distribution Coefficient, logD

-0.380

Water Solubility, LogSw

-5.63

Polar Surface Area

5.064

Acid Dissociation Constant (pKa)

25.34

Base Dissociation Constant (pKb)

13.42

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

39.10

H025-0300C in Drug Discovery

Included in Screening Libraries

Allosteric Kinases Inhibitors Library (23117 compounds)

DGK Inhibitors Library (10558 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Female
  • Congenital
  • Skin
  • Cancer
  • Digestive system
  • Hemic and lymphatic
  • Skin
  • Metabolic
  • Immune system
Targets:
  • Kinases
  • Kinases

References: we are preparing a list of scientific research reports with H025-0300C chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound H025-0300C?
Check Price and Availability of H025-0300C, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of H025-0300C you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for H025-0300C
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for H025-0300C
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of H025-0300C available by request